Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma

Gemcitabine (GEM), a commonly used chemotherapeutic agent in hepatocellular carcinoma (HCC) patients, uses oxidative stress induction as a common effector pathway. However, GEM alone or in combination with oxaliplatin hardly renders any survival benefits to HCC patients. We have recently shown that...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guangsheng, Wang, Jianlu, Xu, Kesen, Dong, Jiahong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2016
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293557/
https://www.ncbi.nlm.nih.gov/pubmed/27129291
http://dx.doi.org/10.1042/BSR20160062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293557/
https://www.ncbi.nlm.nih.gov/pubmed/27129291
http://dx.doi.org/10.1042/BSR20160062

Ejemplares similares